Target intelligence / Profile preview

Pseudogene similar to part of Pituitary tumor-transforming 1 (ENSG00000223866)

Target
ENSG00000223866
Molecular classification
Other, pseudogene, long non-coding RNA
01

Overview

ENSG00000223866 is a pseudogene that resembles a fragment of the protein-coding Pituitary tumor-transforming 1 (PTTG1) gene, but does not produce a functional protein. PTTG1 itself is a well-characterized proto-oncogene involved in cell cycle regulation, DNA repair, tumorigenesis, and is upregulated in multiple cancer types including oral and esophageal squamous cell carcinoma. By contrast, this pseudogene is not considered a therapeutic target and does not have established molecular function or disease relevance as a direct marker or drug target. Pseudogenes in general can have regulatory roles in gene expression, sometimes functioning as long non-coding RNAs (lncRNAs). Some research suggests related pseudogenes, such as PTTG3P, may modulate cancer biology by non-coding RNA activity, but direct functional or biomarker evidence for ENSG00000223866 is lacking. In summary, ENSG00000223866 is a non-coding pseudogene with homology to the oncogenic PTTG1 but is not an established molecular target and should not be considered therapeutically actionable based on current knowledge.

Other names
PTTG1PPTTG3PPTTG1 pseudogene
02

Mechanism of action

None (no mechanisms of action reported for drugs on this pseudogene)

03

Biological functions

Otherpossible suggested regulatory function via lncRNA mechanisms in cancer and gene regulation (not established)
04

Disease associations

Possible Other/Cancer (some pseudogenes can act as non-coding RNA regulators and have been implicated in tumor biology by influencing parental gene expression, but not specifically for ENSG00000223866)

Beyond the preview

Go deeper on Pseudogene similar to part of Pituitary tumor-transforming 1 (ENSG00000223866).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Pseudogene similar to part of Pituitary tumor-transforming 1 (ENSG00000223866).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call